Notizie e Video - Azioni

Regulatory News: Voluntis (Paris:VTX) : Article L233-8-II du Code du Commerce Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation: marché réglementé d’Euronext à Paris Compartiment: Compartiment C Code ISIN: FR0004183960 Site web: www.voluntis.com Date Nombre de titres composant le capital en circulation Nombre total de droits de vote Nombre total de droits de vote théoriques (1) Nombre total de droits de vote exerçables (2) 30 novembre 2019...

Wirecard Provides Seamless Payment Solutions to Ride Hailing Platform CarGo Technologies PR Newswire ASCHHEIM, Germany, Dec. 6, 2019 In-app payments planned to be handled by Wirecard with an expanded strategic focus CarGo Technologies has over 800,000 registered users and more than 4,000 partners to provide roadside services across Europe Collaboration supports Wirecard's megatrend, 'Commerce on the Move': the mobility services market in Europe is expected to surpass EUR 400 billion by 2030...

Equinor has on 5 December 2019 purchased 632,746 own shares at Oslo Stock Exchange at an average price of 168.7353 Norwegian kroner per share. These share purchases form part of the first tranche of the company's share buy-back programme 2019-2022 announced on 5 September 2019. After this transaction Equinor owns a total of 21,341,311 own shares under the share buy-back programme. For further information about the share buy-back programme, reference is made to the Oslo Stock Exchange...

皇家地产Northacre诺诚闪耀双城 PR Newswire 北京, 2019年12月6日 北京2019年12月6日 /美通社/ -- 近日，伦敦高端皇家地产Northacre诺诚分别在上海和北京双城，与伦敦高端珠宝品牌Beau Han Xu以及Beau Han Xu合伙人 -- 北京众乐传媒Kiki Zhang女士，一起成功举办了皇家珠宝“A ROYAL...

Press release - Paris, December 6, 2019 Sharp market deterioration in Hong-Kong SMCP adjusts its 2019 adj. Ebitda margin target and confirms its full-year sales growth outlook SMCP today announces an adjustment to its adj. Ebitda margin objective for 2019 mainly due to the sharp market deterioration in Hong Kong triggered by a significant drop in traffic and temporary store closures over the past few weeks. This deterioration is expected to have a strong impact on the Group’s Ebitda margin. To...

Regulatory News: Celyad (Euronext Bruxelles et Paris, et Nasdaq : CYAD), une société biopharmaceutique de stade clinique spécialisée dans le développement des thérapies cellulaires CAR-T, annonce aujourd’hui qu’elle s’est vu octroyer 2,5 millions EUR de financement non-dilutif. Ce montant comprend 2,1 millions EUR de financement non-dilutif du SPW-Recherche de la Région Wallonne, qui soutiendra le développement des candidats CAR-T de la Société pour le traitement des tumeurs...

Regulatory News: Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today announced that the Company has received €2.5 million in non-dilutive funding. The amount is comprised of €2.1 million in non-dilutive funding from the SPW-Recherche of the Walloon Region, which will support the development of the company’s CAR-T candidates for the treatment of solid tumors, and €0.4 million of...

BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 05 Dec 2019. Estimated NAV Euro Shares Sterling Shares Estimated NAV € 22.7187 £ 20.5502 Estimated MTD return 0.32 % 0.35 % Estimated YTD return 3.25 % 4.61 % Estimated ITD return 127.19 % 105.50 % NAV and returns are calculated net of management and performance fees Market information Euro Shares Amsterdam...